Medical Condition News

RSS

More than half of the patients experience long-term aftereffects of COVID-19

Various long-term effects have been found to occur after infection by the novel coronavirus (COVID-19), and the reality of these lingering symptoms remains unknown.

24 Feb 2023

Digital cognitive behavioral therapy reduces blood sugar levels in patients with diabetes

People with Type 2 diabetes who were given a smartphone app that delivers personalized cognitive behavioral therapy (CBT) saw significantly greater reductions in their blood sugar and less need for higher doses of diabetes medications at six months compared with those who only received standard diabetes care and a control app, in a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

24 Feb 2023

Insomnia patients 69% more likely to have a heart attack

People who suffer from insomnia were 69% more likely to have a heart attack compared to those who didn't have the sleep disorder during an average nine years of follow-up, according to new research being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

24 Feb 2023

More frequent cannabis use associated with higher risk of coronary artery disease

People who used marijuana daily were found to be about one-third more likely to develop coronary artery disease (CAD) compared with people who have never used the drug, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

24 Feb 2023

Head injuries may contribute to the development of glioma

Researchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the development of a relatively rare but often aggressive form of brain tumor called a glioma.

24 Feb 2023

Long-term exposure to air pollution linked to increased risk of heart disease

Long-term exposure to air pollution is tied to an increased risk of having a heart attack or dying from heart disease - with the greatest harms impacting under-resourced communities, new Kaiser Permanente research shows.

24 Feb 2023

New discovery could shift the focus of Parkinson’s disease treatment

Researchers from the University of Queensland have identified that a gene associated with an increased risk of Parkinson's Disease also contributes to a build-up of cell debris in the brain.

24 Feb 2023

Discovery of a T cell subset points to new treatment for COPD exacerbations

Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common diagnoses for hospital admissions.

24 Feb 2023

Physical activity more effective than counseling or medications to manage depression

University of South Australia researchers are calling for exercise to be a mainstay approach for managing depression as a new study shows that physical activity is 1.5 times more effective than counseling or the leading medications.

24 Feb 2023

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

A decade-long international study into kidney cancer has shown that doctors can predict the likelihood of a patient's disease returning by looking at DNA mutations in their tumors.

24 Feb 2023

Apolipoprotein E4 promotes the development of Alzheimer’s disease

Researchers characterize the effects of neuronal apolipoprotein E4 on Alzheimer’s disease-associated pathology.

23 Feb 2023

NQO2 gene as a novel potential target in Parkinson’s disease

A new study under review at the journal Scientific Reports and currently available on the Research Square* preprint server aimed to analyze the toxic effects of 6OHDA along with a related role of NQO2 in murine and human astrocytes.

23 Feb 2023

Study of adult e-cigarette users' attempts and experiences of quitting

Many e-cigarette (vape) users intend to quit, but there are few evidence-based interventions to help them do so. Due to this lack of interventions for e-cigarette cessation, researchers in the United States studied how and why users attempt to quit independently. The study, published in the journal Environmental Research and Public Health, analyzed both barriers and facilitators to quitting e-cigarettes.

23 Feb 2023

Medical Condition News

More than half of the patients experience long-term aftereffects of COVID-19

Digital cognitive behavioral therapy reduces blood sugar levels in patients with diabetes

Insomnia patients 69% more likely to have a heart attack

More frequent cannabis use associated with higher risk of coronary artery disease

Head injuries may contribute to the development of glioma

Long-term exposure to air pollution linked to increased risk of heart disease

New discovery could shift the focus of Parkinson’s disease treatment

Discovery of a T cell subset points to new treatment for COPD exacerbations

Physical activity more effective than counseling or medications to manage depression

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

Apolipoprotein E4 promotes the development of Alzheimer’s disease

NQO2 gene as a novel potential target in Parkinson’s disease

Study of adult e-cigarette users' attempts and experiences of quitting

Study: Millions of Americans continued to miss cancer screening tests during the second year of pandemic

Community health worker-led intervention effective in achieving blood pressure control among South Asian Americans

Mystical and insightful psychedelic experience may be linked to positive mental health outcomes

UMSOM researchers unravel the molecular components involved in abdominal aneurysms

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

Pennington Biomedical assistant professor seeks to better understand why people with diabetes develop hypoglycemia

Novel fatty liver organoid models could aid in drug discovery and testing

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News